DVA - DaVita Inc.

NYSE - NYSE Delayed Price. Currency in USD
70.52
+1.49 (+2.16%)
At close: 4:06PM EST
Stock chart is not supported by your current browser
Previous Close69.03
Open69.13
Bid0.00 x 0
Ask0.00 x 0
Day's Range69.03 - 70.64
52 Week Range52.51 - 71.47
Volume3,010,422
Avg. Volume2,570,774
Market Cap12.929B
Beta1.04
PE Ratio (TTM)26.53
EPS (TTM)2.66
Earnings DateFeb 14, 2018 - Feb 19, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est72.85
Trade prices are not sourced from all markets
  • American City Business Journalsyesterday

    DaVita settles False Claims Act allegations for $64 million

    DaVita Inc. will pay $63.7 million to settle a whistle-blower lawsuit that alleged that the Denver-based company’s pharmaceutical division improperly billed the federal government for medications that were not used by patients and that it paid financial inducements to beneficiaries in violation of the federal anti-kickback laws. Two former DaVita employees also filed a whistle-blower lawsuit in U.S. District Court in northern Texas in 2016. This latest settlement follows DaVita agreeing to pay $389 million in 2014 to settle anti-kickback allegations surrounding joint ventures made with nephrologists and agreeing to pay $495 million in 2015 on a whistle-blower settlement regarding its billing over certain drugs that were only partially dispensed.

  • Associated Press2 days ago

    Texas-based DaVita Rx to pay nearly $64M in billing dispute

    A Texas-based pharmacy chain that specializes in patients with kidney problems will pay nearly $64 million to settle allegations of improper billing and other disputed financial practices. Federal prosecutors ...

  • DaVita Kidney Care Issues Statement about DaVita Rx Settlement
    PR Newswire2 days ago

    DaVita Kidney Care Issues Statement about DaVita Rx Settlement

    DENVER , Dec. 14, 2017 /PRNewswire/ -- The following media statement is attributable to DaVita (NYSE: DVA). We take full ownership and continue to embrace transparency and rigorous compliance. DaVita is ...

  • Reuters2 days ago

    DaVita pharmacy unit settles U.S. billing probe for $63.7 million

    A pharmacy services unit of DaVita Inc will pay $63.7 million to resolve allegations that it improperly billed federal healthcare programs for medications and paid illegal financial inducements to patients, the U.S. Justice Department said. The settlement announced on Thursday will resolve an investigation by the Justice Department into DaVita Rx LLC, a national pharmacy that specializes in serving kidney disease patients.

  • Reuters2 days ago

    DaVita unit to pay $63.7 million to resolve U.S. billing probe

    A pharmacy services unit of DaVita Inc has agreed to pay $63.7 million to resolve allegations that it improperly billed federal healthcare programs for medications and paid illegal financial inducements ...

  • DaVita Addresses Physician Fatigue with Investment in DaVita Physician Solutions
    PR Newswire2 days ago

    DaVita Addresses Physician Fatigue with Investment in DaVita Physician Solutions

    DaVita Physician Solutions helps solve for the physician experience through modern technology solutions DENVER , Dec. 14, 2017 /PRNewswire/ --  DaVita Inc. (NYSE: DVA), a leading independent medical group ...

  • DaVita Kidney Care Serves Up 'Home-Cooked Holidays' Cookbook
    PR Newswire3 days ago

    DaVita Kidney Care Serves Up 'Home-Cooked Holidays' Cookbook

    DENVER , Dec. 13, 2017 /PRNewswire/ --  DaVita Kidney Care , a division of DaVita Inc. (NYSE: DVA), a leading provider in kidney care services, released its "Today's Kidney Diet: Home-Cooked Holidays" ...

  • GuruFocus.com4 days ago

    Davita Inc (DVA) Chairman and CEO Kent J Thiry Sold $5.6 million of Shares

    Chairman and CEO of Davita Inc (NYSE:DVA) Kent J Thiry sold 81,800 shares of DVA on 12/08/2017 at an average price of $68.04 a share.

  • CVS-Aetna Deal Leading a Wave of Change in Hospital Sector
    Zacks4 days ago

    CVS-Aetna Deal Leading a Wave of Change in Hospital Sector

    Increased consolidation is being witnessed in the hospital sector as a defense against invasion by new comers.

  • Barrons.com4 days ago

    DaVita: Cash Flows from Kidney Care?

    After a divestiture deal that could raise nearly $5 billion for kidney dialysis leader DaVita (DVA) is now 13% higher than the level where Barron's warned that insurers were attacking DaVita's profits ("Insurers Press Dialysis Claims," September 2, 2017). Bulls like John Ransom at Raymond James expect the company to repurchase stock and pay down debt with the proceeds from a December 6 deal to sell its medical practices to UnitedHealth Group (UNH). On December 7, the Raymond James analyst raised his rating on DaVita shares from Outperform to a Strong Buy, while upping his price target from $65 to $84.

  • MarketWatch6 days ago

    UnitedHealth is stepping past CVS Health with its latest deal

    While rivals are copying UnitedHealth, the company has raised the bar again, one Wall Street analyst said.

  • Dow 30 Stock Roundup: UnitedHealth to Buy DaVita Unit for $4.9B, Chevron to Cut CapEx in 2018
    Zacks8 days ago

    Dow 30 Stock Roundup: UnitedHealth to Buy DaVita Unit for $4.9B, Chevron to Cut CapEx in 2018

    The Dow endured a volatile week even as Republicans tasted success on the tax legislation front.

  • UnitedHealth on A.M.Best's Radar After Buyout Announcement
    Zacks8 days ago

    UnitedHealth on A.M.Best's Radar After Buyout Announcement

    A.M.Best acknowledges UnitedHealth's(UNH) deleveraging strategy and earnings accretion from DaVita Medical Group acquisition.

  • ACCESSWIRE8 days ago

    Wired News – DaVita Sells DaVita Medical Group to UnitedHealth Group’s Optum

    Stock Monitor: DaVita Post Earnings Reporting LONDON, UK / ACCESSWIRE / December 08, 2017 / Active-Investors issued a free report on UnitedHealth Group Inc. (NYSE: UNH ), which is readily accessible upon ...

  • Moody's9 days ago

    DaVita Inc. -- Moody's affirms DaVita's Ba2 CFR; outlook stable

    Rating Action: Moody's affirms DaVita's Ba2 CFR; outlook stable. Global Credit Research- 07 Dec 2017. New York, December 07, 2017-- Moody's Investors Service announced that it affirmed all ratings of DaVita, ...

  • Company News For Dec 7, 2017
    Zacks9 days ago

    Company News For Dec 7, 2017

    Companies In The News are: PLAY,OXM,HRB,DVA,UNH

  • DaVita (DVA) Surges: Stock Moves 13.6% Higher
    Zacks9 days ago

    DaVita (DVA) Surges: Stock Moves 13.6% Higher

    DaVita (DVA) saw a big move last session, as its shares jumped nearly 14% on the day, amid huge volumes

  • UnitedHealth to Buy DaVita Medical, Expands Optum Business
    Zacks9 days ago

    UnitedHealth to Buy DaVita Medical, Expands Optum Business

    UnitedHealth's (UNH) intention to buy DaVita Medical reflects its continuous effort to build up a vertically integrated business model

  • InvestorPlace9 days ago

    UnitedHealth Group Inc Stock Is a Buy on Davita Acquisition

    UnitedHealth Group Inc (NYSE:UNH), the dominant player in the U.S. health insurance market, has agreed to buy the medical clinic business of Davita Inc (NYSE:DVA) for $4.9 billion, accelerating consolidation in the healthcare space. This could mean good things for UNH stock. In describing the pending merger of CVS Health Corp (NYSE:CVS) and Aetna Inc (NYSE:AET), health insurers are looking to buy facilities and drug dispensing units so they can gain control over costs.

  • The Wall Street Journal9 days ago

    UnitedHealth to Buy Large Doctor Group for $4.9 Billion

    As CVS Health and Aetna seek to build an integrated health care company without doctors, rival UnitedHealth Group makes $4.9 billion deal to add more providers.

  • Barrons.com10 days ago

    The Hot Stock: DaVita Got How Much From UnitedHealth?!?!

    DaVita (DVA) soared to the top of the S&P 500 today after it sold its Medical Group for nearly $5 billion to UnitedHealth Group (UNH). DaVita gained 14% to $69.20 today, while the S&P 500 finished little changed at 2629.27. UnitedHealth dipped 0.1% to $219.94.

  • Associated Press10 days ago

    DaVita and AeroVironment jump while Fred's and Patterson dip

    Stocks that moved substantially or traded heavily Wednesday: DaVita Inc., up $8.27 to $69.20 The dialysis services company agreed to sell a physician practice business to health insurer UnitedHealth for ...

  • UnitedHealth to buy DaVita primary care unit for $4.9 billion
    Reuters10 days ago

    UnitedHealth to buy DaVita primary care unit for $4.9 billion

    Health insurers are trying to cut medical costs by playing a more direct role in medical services, arguing they can save money by shifting patients to cheaper, more accessible locations for routine or non life-threatening emergency medical services. On Sunday, No. 3 health insurer Aetna Inc agreed to be bought by CVS Health as part of a drive to expand medical services at CVS pharmacies to include more preventative screenings such as for vision and hearing.

  • TheStreet.com10 days ago

    Aetna CEO to Receive $500 Million Once CVS Deal Closes: MARKETS LIVE

    Mark Bertolini's stock options total in the hundreds of millions of dollars.